483 Abraxis Bioscience Aug 2014

483 Abraxis Bioscience Aug 2014

Linda Murphy FDA, Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the Abraxis Bioscience - Phoenix, AZ, United States facility and issued 2 inspectional observations (via FDA 483) on 08 Aug 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 08 Aug 2014
  • Location: Phoenix, United States
  • FEI: 3006441852
Add To Cart